Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,027,518
-$3,406,586 QoQ
Shares Held
1,871,217
+46.6% QoQ
Ownership
0.537%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. NUVB ranks #155 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,027,518 | 1,871,217 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,434,104 | 1,276,128 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $4,882,129 | 1,319,495 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $2,359,113 | 1,209,803 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $3,467,146 | 1,969,970 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,853,742 | 1,072,836 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,708,771 | 1,182,871 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $3,032,961 | 1,038,686 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $4,301,024 | 1,181,601 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,211,838 | 802,544 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $595,623 | 444,498 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,105,619 | 614,234 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $744,740 | 448,641 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $834,992 | 434,894 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $449,730 | 200,774 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $590,895 | 182,376 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $628,839 | 119,552 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,421,776 | 167,268 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $763,974 | 76,859 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $488,216 | 52,440 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $528,247 | 50,550 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||